Miriam Onrubia

Miriam Onrubia

Auto-generated profile, based on publicly available information

Miriam Onrubia

Departament de Ciències Experimentals i de Salut, Universitat Pompeu Fabra, E-08003 Barcelona, Spain

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Biotechnology Advances
Verified
Journal Article
Closed access
RCRosa M. Cusido
Rosa M. Cusido
MOMiriam Onrubia
Miriam Onrubia
ASAna Belén Sabater-Jara
Ana Belén Sabater-Jara
EMElisabet Moyano
Elisabet Moyano
Mercedes BonfillMercedes Bonfill
Mercedes Bonfill
JPJavier Palazon
Javier Palazon

1 January 2013 in Journal of Plant Physiology
Verified
Journal Article
Closed access
MOMiriam Onrubia
Miriam Onrubia
EMElisabet Moyano
Elisabet Moyano
Mercedes BonfillMercedes Bonfill
Mercedes Bonfill
RCRosa Mª Cusidó
Rosa Mª Cusidó
AGAlain Goossens
Alain Goossens
JPJavier Palazon
Javier Palazon

1 January 2009 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
OEO. Exposito
O. Exposito
MBM. Bonfill
M. Bonfill
EME. Moyano
E. Moyano
MOM. Onrubia
M. Onrubia
MMM. H. Mirjalili
M. H. Mirjalili
JPJavier Palazon
Javier Palazon
Taxol is one of the most effective anti-cancer drugs ever developed. The natural source of taxol is the inner bark of several Taxus species, but it accumulates at a very low concentration and with a prohibitively high cost of extraction. Another problem is that the use of inner bark for taxol production implies the destruction of yew trees. For all these reasons, the growing demand for taxol greatly exceeds the supply that can be sustained by isolation from its natural source and alternative sources of the drug are being sought. Although taxol has been prepared by total synthesis, the process is not commercially viable. Taxol can also be semisynthetically produced via the conversion of baccatin III or 10-deacethylbaccatinIII found in Taxus needles but the cost and difficulty of the extraction process of the semisynthetic precursors are also very high. The most promising approach for the sustainable production of taxol and related taxoids is provided by plant cell cultures at an industrial level. Taxol is currently being clinically used against different tumour processes but due to the difficulty of its extraction and formulation, as well as the growing demand for the compound, new taxol analogues with improved properties are being studied. In this revision we discuss current research in the design of new taxol-related compounds, the chemical structure/anti-cancer activity relationship and new formulations of the drug. We also consider the optimizing strategies to improve taxol and related taxoid production in cell cultures, as well as the current knowledge of taxol metabolism, all of which are illustrated with examples, some of them from our own research.

9 June 2014 in Plant Biotechnology Journal
Verified
Journal Article
Closed access
PDF file
ASAna‐Belén Sabater‐Jara
Ana‐Belén Sabater‐Jara
MOMiriam Onrubia
Miriam Onrubia
EMElisabeth Moyano
Elisabeth Moyano
Mercedes BonfillMercedes Bonfill
Mercedes Bonfill
JPJavier Palazon
Javier Palazon
RCRosa M. Cusidó
Rosa M. Cusidó

24 March 2010 in Biotechnology Progress
Verified
Journal Article
Closed access
PDF file
OEOscar Exposito
Oscar Exposito
KSKatarzyna Sykłowska-Baranek
Katarzyna Sykłowska-Baranek
EMElisabeth Moyano
Elisabeth Moyano
MOMiriam Onrubia
Miriam Onrubia
Mercedes BonfillMercedes Bonfill
Mercedes Bonfill
RCRosa M. Cusido
Rosa M. Cusido

21 April 2015 in Plant Biotechnology Journal
Verified
Journal Article
Open access
PDF file
Karla Ramirez-EstradaKarla Ramirez-Estrada
Karla Ramirez-Estrada
Teresa AltabellaTeresa Altabella
Teresa Altabella
MOMiriam Onrubia
Miriam Onrubia
EMElisabeth Moyano
Elisabeth Moyano
CNCedric Notredame
Cedric Notredame
JPJavier Palazon
Javier Palazon
Summary: Plant cell cultures constitute eco‐friendly biotechnological platforms for the production of plant secondary metabolites with pharmacological activities, as well as a suitable system for extending our knowledge of secondary metabolism. Despite the high added value of taxol and the importance of taxanes as anticancer compounds, several aspects of their biosynthesis remain unknown. In this work, a genomewide expression analysis of jasmonate‐elicited Taxus baccata cell cultures by complementary DNA‐amplified fragment length polymorphism (cDNA‐AFLP) indicated a correlation between an extensive elicitor‐induced genetic reprogramming and increased taxane production in the targeted cultures. Subsequent in silico analysis allowed us to identify 15 genes with a jasmonate‐induced differential expression as putative candidates for genes encoding enzymes involved in five unknown steps of taxane biosynthesis. Among them, the TB768 gene showed a strong homology, including a very similar predicted 3D structure, with other genes previously reported to encode acyl‐CoA ligases, thus suggesting a role in the formation of the taxol lateral chain. Functional analysis confirmed that the TB768 gene encodes an acyl‐CoA ligase that localizes to the cytoplasm and is able to convert β‐phenylalanine, as well as coumaric acid, into their respective derivative CoA esters. β‐phenylalanyl‐CoA is attached to baccatin III in one of the last steps of the taxol biosynthetic pathway. The identification of this gene will contribute to the establishment of sustainable taxol production systems through metabolic engineering or synthetic biology approaches.